Skip to Content

Committed to Safety: As we resume services, we are taking all necessary precautions to keep you safe while we care for you. Limited visitation is now in place. Review all our visitor policies and precautions. Get more information on COVID-19.

Clinical Trials Details

Merck MK7902-007

Patient Information

A Phase 3, randomized, double-blind trial of pembrolizumab (MK-3475) with or without lenvatinib (E7080/MK-7902) in participants with treatment-naïve, metastatic non-small cell lung cancer (NSCLC) whose tumors have a tumor proportion score (TPS) greater than or equal to 1%.

Learn more about clinical trial: Merck MK7902-007

Clinical Trial Categories

  • Lung Cancer - Metastatic

Location

  • Cone Health Cancer Center at Alamance Regional
    1236 Huffman Mill Rd.
    Burlington, NC 27215
    Main: 336-538-7725
  • Cone Health Cancer Center at Wesley Long
    2400 W. Friendly Avenue
    Greensboro, NC 27403
    Main: 336-832-1100